CISEN-辰欣药业(603367) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was CNY 1,148,946,834.25, representing a year-on-year increase of 1.28%[6] - Net profit attributable to shareholders was CNY 162,863,217.96, reflecting a growth of 4.50% compared to the same period last year[6] - Total operating revenue for Q1 2024 was approximately ¥1.15 billion, a slight increase of 1.5% compared to ¥1.13 billion in Q1 2023[24] - Net profit for Q1 2024 reached approximately ¥162.18 million, representing an increase of 3.1% from ¥157.21 million in Q1 2023[25] - Operating profit for Q1 2024 was ¥142,970,237.88, down 13.0% from ¥164,118,173.52 in Q1 2023[32] - Net profit for Q1 2024 was ¥129,419,933.08, a decline of 13.0% compared to ¥148,665,145.47 in Q1 2023[32] Cash Flow - The net cash flow from operating activities increased significantly by 145.25%, amounting to CNY 245,031,646.54[6] - Cash flow from operating activities generated a net inflow of approximately ¥245.03 million, compared to ¥99.91 million in Q1 2023, indicating a significant improvement[27] - Cash flow from operating activities generated a net amount of ¥182,959,351.08 in Q1 2024, compared to ¥98,805,509.39 in Q1 2023, indicating improved cash generation[35] - The cash flow from operating activities was not detailed, but the overall cash and cash equivalents decreased by $59.2 million[36] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 7,557,195,630.90, a 2.99% increase from the previous year[7] - The company's total current assets reached RMB 5,154,438,741.58, up from RMB 4,969,807,069.20, indicating an increase of about 3.7%[18] - The total liabilities of the company were RMB 1,617,622,267.54, compared to RMB 1,571,382,826.12, marking an increase of about 2.9%[20] - Total assets as of Q1 2024 were ¥6,774,469,544.92, an increase from ¥6,647,041,911.57 in Q1 2023[31] - Total liabilities for Q1 2024 were ¥1,417,009,755.18, slightly down from ¥1,419,002,054.91 in Q1 2023[31] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 21,273[13] - The largest shareholder, Chenxin Technology Group Co., Ltd., held 26.26% of the shares, amounting to 118,891,080 shares[14] - The company's equity attributable to shareholders was CNY 5,895,008,400.17, marking a 2.93% increase from the end of the previous year[7] - The company's total equity increased to ¥5,357,459,789.74 in Q1 2024, up from ¥5,228,039,856.66 in Q1 2023, reflecting a stronger financial position[31] Expenses - Total operating costs decreased to approximately ¥954.82 million, down 1.0% from ¥964.57 million in the same period last year[24] - Research and development expenses increased to ¥81,709,281.41 in Q1 2024, up from ¥77,150,126.75 in Q1 2023, reflecting a focus on innovation[32] - The company reported a tax expense of approximately ¥21.51 million for Q1 2024, an increase from ¥14.10 million in Q1 2023[25] - The company reported a decrease in sales expenses to ¥320,168,405.25 in Q1 2024 from ¥355,620,744.39 in Q1 2023, indicating cost management efforts[32] Other Income and Receivables - Other receivables increased by 149.35%, indicating a rise in business-related receivables during the reporting period[11] - The company reported a 517.56% increase in other income, primarily due to an increase in government subsidies recognized in the current period[11] Cash and Cash Equivalents - Cash and cash equivalents decreased to RMB 937,039,700.37 from RMB 983,389,232.24, a decline of approximately 4.7%[18] - Cash and cash equivalents at the end of Q1 2024 totaled approximately ¥937.04 million, a decrease from ¥983.39 million at the beginning of the quarter[28] - The ending cash and cash equivalents balance was$ 752.1 million, down from $759.7 million in the previous period[36] Investment Activities - Investment activities resulted in a net cash outflow of approximately ¥221.44 million in Q1 2024, compared to a net outflow of ¥186.14 million in Q1 2023[28] - The net cash flow from investment activities was -$ 234 million, compared to - $184 million in the previous period, indicating a decline in investment performance[36] - Total cash outflow for investment activities was$ 874.9 million, which is a decrease from $1.15 billion in the previous period[36] Accounting Standards - The company is implementing new accounting standards starting in 2024, which may affect future financial reporting[36]